The role of targeted agents in adjuvant therapy for non-small cell lung cancer.

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

The recent survival benefit of adjuvant chemotherapy in early stage non-small cell lung cancer provides optimism for the future success of targeted therapy in this setting. It is important that we begin to explore molecularly targeted agents in the adjuvant arena, but how best to accomplish this in the face of these new findings presents a challenge. Criteria for selecting promising targeted therapies and optimal trial designs to evaluate them expeditiously in the adjuvant setting are clearly needed.

Original languageEnglish (US)
JournalClinical cancer research : an official journal of the American Association for Cancer Research
Volume11
Issue number13 Pt 2
StatePublished - Jul 1 2005
Externally publishedYes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'The role of targeted agents in adjuvant therapy for non-small cell lung cancer.'. Together they form a unique fingerprint.

  • Cite this